- Published on
Infectious disease and microbiology – Otitis externa
Otitis externa is an infection of the external auditory canal and is classified into four main types: acute localized, acute diffuse (swimmer’s ear), chronic, and invasive (malignant or necrotizing) otitis externa, the latter being a severe form that extends beyond the ear canal into surrounding soft tissue and bone. While most forms are common—affecting approximately 4 per 1000 people annually—the invasive form is rare but potentially life-threatening.
Risk factors vary by type. Hot, humid climates, frequent water exposure, and mechanical trauma (e.g., scratching or use of cotton swabs) predispose to acute diffuse otitis externa. In contrast, elderly patients, diabetics, and immunocompromised individuals are at higher risk for the invasive form. Preventive strategies include avoiding trauma to the ear canal and maintaining good diabetic control.
Pathophysiologically, disruption of the ear canal’s natural defenses—such as reduced acidity or decreased antimicrobial components like lysozyme and immunoglobulins (IgA, IgG)—facilitates microbial growth. Pseudomonas aeruginosa plays a key role, particularly in invasive disease, through increased expression of virulence factors such as exotoxins.
The etiology depends on the subtype. Acute localized infections (furuncles) are typically caused by Staphylococcus aureus. Acute diffuse otitis externa is most commonly due to Pseudomonas aeruginosa, along with other gram-negative bacteria, S. aureus, and occasionally fungi like Aspergillus. Chronic otitis externa is often related to persistent irritation from middle ear infections. Invasive otitis externa is most frequently caused by P. aeruginosa (>95% of cases), though other bacteria and fungi may be involved.
Clinically, patients with acute disease present with ear pain (otalgia), itching (pruritus), and sometimes discharge, with pain often worsened by manipulation of the auricle. Chronic cases tend to cause itching rather than pain. Invasive otitis externa presents more severely, with intense pain, purulent drainage, granulation tissue in the ear canal, and possible cranial nerve involvement (especially facial nerve palsy).
Diagnosis is primarily clinical and relies heavily on otoscopic examination. In invasive disease, laboratory findings may show a normal white blood cell count but elevated erythrocyte sedimentation rate. Imaging with CT (for bone involvement) and MRI (for soft tissue extension) is essential to assess disease extent. Deep tissue biopsy may be required to confirm diagnosis and exclude malignancy.
Treatment depends on severity. Topical antibiotic drops (often combined with corticosteroids) are the mainstay for uncomplicated cases, along with ear canal cleaning and moisture avoidance. Oral antibiotics are used if local therapy fails. Invasive otitis externa requires prolonged intravenous antipseudomonal antibiotics (6–8 weeks) such as ciprofloxacin, ceftazidime, cefepime, or carbapenems, along with meticulous canal care. Antifungal therapy is indicated when fungal pathogens are identified.
The prognosis is generally excellent for uncomplicated cases. In invasive otitis externa, outcomes have improved significantly, with up to 95% cure rates, although prognosis worsens with cranial nerve involvement, fungal infection, bilateral disease, or underlying immunosuppression.
Complications of invasive disease can be severe and include spread to the skull base, cranial nerve palsies, sigmoid sinus thrombosis, meningitis, and brain infection, making early recognition and aggressive treatment critical.
Otitis externa is an infection of the external auditory canal and is classified into four main types: acute localized, acute diffuse (swimmer’s ear), chronic, and invasive (malignant or necrotizing) otitis externa, the latter being a severe form that extends beyond the ear canal into surrounding soft tissue and bone. While most forms are common—affecting approximately 4 per 1000 people annually—the invasive form is rare but potentially life-threatening.
Risk factors vary by type. Hot, humid climates, frequent water exposure, and mechanical trauma (e.g., scratching or use of cotton swabs) predispose to acute diffuse otitis externa. In contrast, elderly patients, diabetics, and immunocompromised individuals are at higher risk for the invasive form. Preventive strategies include avoiding trauma to the ear canal and maintaining good diabetic control.
Pathophysiologically, disruption of the ear canal’s natural defenses—such as reduced acidity or decreased antimicrobial components like lysozyme and immunoglobulins (IgA, IgG)—facilitates microbial growth. Pseudomonas aeruginosa plays a key role, particularly in invasive disease, through increased expression of virulence factors such as exotoxins.
The etiology depends on the subtype. Acute localized infections (furuncles) are typically caused by Staphylococcus aureus. Acute diffuse otitis externa is most commonly due to Pseudomonas aeruginosa, along with other gram-negative bacteria, S. aureus, and occasionally fungi like Aspergillus. Chronic otitis externa is often related to persistent irritation from middle ear infections. Invasive otitis externa is most frequently caused by P. aeruginosa (>95% of cases), though other bacteria and fungi may be involved.
Clinically, patients with acute disease present with ear pain (otalgia), itching (pruritus), and sometimes discharge, with pain often worsened by manipulation of the auricle. Chronic cases tend to cause itching rather than pain. Invasive otitis externa presents more severely, with intense pain, purulent drainage, granulation tissue in the ear canal, and possible cranial nerve involvement (especially facial nerve palsy).
Diagnosis is primarily clinical and relies heavily on otoscopic examination. In invasive disease, laboratory findings may show a normal white blood cell count but elevated erythrocyte sedimentation rate. Imaging with CT (for bone involvement) and MRI (for soft tissue extension) is essential to assess disease extent. Deep tissue biopsy may be required to confirm diagnosis and exclude malignancy.
Treatment depends on severity. Topical antibiotic drops (often combined with corticosteroids) are the mainstay for uncomplicated cases, along with ear canal cleaning and moisture avoidance. Oral antibiotics are used if local therapy fails. Invasive otitis externa requires prolonged intravenous antipseudomonal antibiotics (6–8 weeks) such as ciprofloxacin, ceftazidime, cefepime, or carbapenems, along with meticulous canal care. Antifungal therapy is indicated when fungal pathogens are identified.
The prognosis is generally excellent for uncomplicated cases. In invasive otitis externa, outcomes have improved significantly, with up to 95% cure rates, although prognosis worsens with cranial nerve involvement, fungal infection, bilateral disease, or underlying immunosuppression.
Complications of invasive disease can be severe and include spread to the skull base, cranial nerve palsies, sigmoid sinus thrombosis, meningitis, and brain infection, making early recognition and aggressive treatment critical.
0 Comments
